3.37
price up icon0.00%   0.00
after-market Handel nachbörslich: 3.34 -0.03 -0.89%
loading
Schlusskurs vom Vortag:
$3.37
Offen:
$3.39
24-Stunden-Volumen:
393.84K
Relative Volume:
0.39
Marktkapitalisierung:
$466.01M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-45.44M
KGV:
-9.6286
EPS:
-0.35
Netto-Cashflow:
$-42.28M
1W Leistung:
-3.44%
1M Leistung:
+18.25%
6M Leistung:
+21.22%
1J Leistung:
+118.83%
1-Tages-Spanne:
Value
$3.29
$3.45
1-Wochen-Bereich:
Value
$3.285
$3.515
52-Wochen-Spanne:
Value
$1.27
$4.08

Compass Therapeutics Inc Stock (CMPX) Company Profile

Name
Firmenname
Compass Therapeutics Inc
Name
Telefon
617-500-8099
Name
Adresse
80 GUEST STREET, BOSTON
Name
Mitarbeiter
35
Name
Twitter
Name
Nächster Verdiensttermin
2025-08-08
Name
Neueste SEC-Einreichungen
Name
CMPX's Discussions on Twitter

Vergleichen Sie CMPX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CMPX
Compass Therapeutics Inc
3.37 474.31M 0 -45.44M -42.28M -0.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-01 Fortgesetzt Raymond James Outperform
2025-04-02 Hochstufung Leerink Partners Market Perform → Outperform
2025-02-24 Eingeleitet Guggenheim Buy
2025-02-19 Eingeleitet Piper Sandler Overweight
2024-12-23 Eingeleitet D. Boral Capital Buy
2024-11-15 Herabstufung Leerink Partners Outperform → Market Perform
2024-09-16 Hochstufung Ladenburg Thalmann Neutral → Buy
2023-01-31 Eingeleitet Jefferies Buy
2023-01-27 Eingeleitet Stifel Buy
2022-05-23 Fortgesetzt H.C. Wainwright Buy
2022-03-15 Eingeleitet Ladenburg Thalmann Buy
2022-01-19 Eingeleitet B. Riley Securities Buy
2021-12-22 Eingeleitet Raymond James Outperform
2021-12-20 Eingeleitet SVB Leerink Outperform
2021-12-15 Eingeleitet Wedbush Outperform
Alle ansehen

Compass Therapeutics Inc Aktie (CMPX) Neueste Nachrichten

pulisher
Sep 03, 2025

Visual analytics tools that track Compass Therapeutics Inc. performance2025 Technical Overview & Fast Momentum Entry Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Has Compass Therapeutics Inc. found a price floor2025 Bull vs Bear & Smart Money Movement Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What’s the recovery path for long term holders of Compass Therapeutics Inc.Trade Risk Report & AI Enhanced Trade Execution Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How hedge fund analytics apply to Compass Therapeutics Inc. stockEarnings Risk Summary & High Accuracy Trade Signal Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Piper Sandler Reaffirms Optimism on Compass Therapeutics (CMPX) Amid Trial Update - MSN

Sep 03, 2025
pulisher
Sep 03, 2025

Relative strength of Compass Therapeutics Inc. in sector analysis2025 Winners & Losers & High Accuracy Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to escape a deep drawdown in Compass Therapeutics Inc.2025 Retail Activity & Safe Investment Capital Preservation Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will Compass Therapeutics Inc. price bounce be sustainableJuly 2025 Opening Moves & Technical Pattern Alert System - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What MACD and RSI say about Compass Therapeutics Inc.July 2025 Setups & Verified Technical Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will earnings trigger a reversal in Compass Therapeutics Inc.Trade Analysis Summary & Short-Term Trading Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can trapped investors hope for a rebound in Compass Therapeutics Inc.July 2025 PreEarnings & Long Hold Capital Preservation Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Sector ETF performance correlation with Compass Therapeutics Inc.Market Volume Summary & Weekly Momentum Stock Picks - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Technical signs of recovery in Compass Therapeutics Inc.July 2025 Sector Moves & Daily Entry Point Trade Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Statistical indicators supporting Compass Therapeutics Inc.’s strength2025 Retail Activity & Community Verified Swing Trade Signals - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Short interest data insights for Compass Therapeutics Inc.2025 Trading Recap & Growth Oriented Trade Recommendations - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Compass Therapeutics Inc. forming a breakout patternEarnings Overview Report & High Yield Equity Trading Tips - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Custom strategy builders for tracking Compass Therapeutics Inc.July 2025 Closing Moves & Free Low Drawdown Momentum Trade Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Can Compass Therapeutics Inc. maintain its current growth ratePortfolio Gains Summary & Low Risk High Win Rate Stock Picks - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Will Compass Therapeutics Inc. outperform during market ralliesPortfolio Value Summary & Verified Short-Term Plans - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Is Compass Therapeutics Inc. a speculative investment2025 Support & Resistance & Consistent Profit Trading Strategies - khodrobank.com

Sep 02, 2025
pulisher
Sep 01, 2025

Stop Loss: What’s the RSI of Compass Therapeutics Inc. stockJuly 2025 Outlook & Verified Chart Pattern Trade Signals - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Will Compass Therapeutics Inc. benefit from macro trends2025 Performance Recap & Technical Pattern Based Signals - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Can Compass Therapeutics Inc. lead its sector in growthOptions Play & Low Drawdown Investment Strategies - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Smart tools for monitoring Compass Therapeutics Inc.’s price action2025 Pullback Review & Weekly Market Pulse Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Using Bollinger Bands to evaluate Compass Therapeutics Inc2025 Geopolitical Influence & Fast Entry Momentum Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Compass Therapeutics Inc. stock retracement – recovery analysisGlobal Markets & Free High Return Stock Watch Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Quarterly Recap: How does Compass Therapeutics Inc. compare to its peersEarnings Growth Report & High Conviction Investment Ideas - khodrobank.com

Sep 01, 2025
pulisher
Aug 31, 2025

Trend analysis for Compass Therapeutics Inc. this weekQuarterly Growth Report & Long-Term Capital Growth Ideas - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Will Compass Therapeutics Inc. stock go up soonJuly 2025 Fed Impact & Advanced Technical Signal Analysis - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Using Bollinger Bands to evaluate Compass Therapeutics Inc.July 2025 Trends & Momentum Based Trading Ideas - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Advanced analytics toolkit walkthrough for Compass Therapeutics Inc.Weekly Stock Report & Daily Oversold Bounce Ideas - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

10 Must-Buy Penny Stocks to Invest In - Insider Monkey

Aug 31, 2025
pulisher
Aug 31, 2025

Technical analysis overview for Compass Therapeutics Inc. stockEarnings Growth Summary & Short-Term High Return Strategies - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Visualizing Compass Therapeutics Inc. stock with heatmapsJuly 2025 PostEarnings & Safe Entry Zone Tips - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

What MACD signals say about Compass Therapeutics Inc.Portfolio Profit Report & Growth Oriented Trade Recommendations - Newser

Aug 31, 2025

Finanzdaten der Compass Therapeutics Inc-Aktie (CMPX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Compass Therapeutics Inc-Aktie (CMPX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
GORDON CARL L
Director
Apr 09 '25
Sale
1.59
3,571,428
5,678,571
0
ORBIMED ADVISORS LLC
Director
Apr 09 '25
Sale
1.59
3,571,428
5,678,571
0
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):